Effect of Ipragliflozin, a new oral hypoglycemic agent, on body composition in patients with diabetes
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000014775
- Lead Sponsor
- Keio University School of Medicine, Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication for Ipragliflozin Patients who had been treated with metformin or GLP-1 analogues Pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ean body mass
- Secondary Outcome Measures
Name Time Method body weight fasting plasma glucose HbA1c free fatty acid (24 fraction)